I agree that this site is using cookies. You can find further informations here.
X
Endrenyi, Laszlo
79  results:
Search for persons X
?
1

Bioequivalence metrics for absorption rates: linearity, spe..:

Tóthfalusi, László ; Endrényi, László ; Vincze, István
Acta Pharmaceutica Hungarica.  89 (2019)  1 - p. 17-21 , 2019
Link: https://doi.org/10.33892..
 
?
2

Panos Macheras: a pioneering scientist in pharmaceutical sc..:

Endrenyi, Laszlo ; Bies, Robert R.
Journal of Pharmacokinetics and Pharmacodynamics.  46 (2019)  2 - p. 105-109 , 2019
Link: https://doi.org/10.1007/..
 
?
3

Interchangeability Of Biological Drug Products—FDA Draft Gu..:

Endrenyi, Laszlo ; Markus, Richard
Journal of Biopharmaceutical Statistics.  29 (2019)  6 - p. 1003-1010 , 2019
Link: https://doi.org/10.1080/..
 
?
4

Summary report of second EUFEPS/AAPS conference on global h..:

Chen, Mei-Ling ; Blume, Henning ; Beuerle, Gerald...
European Journal of Pharmaceutical Sciences.  127 (2019)  - p. 24-28 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Bioequivalence for highly variable drugs: regulatory agreem..:

Endrenyi, Laszlo ; Tothfalusi, Laszlo
Journal of Pharmacokinetics and Pharmacodynamics.  46 (2019)  2 - p. 117-126 , 2019
Link: https://doi.org/10.1007/..
 
?
6

Biosimilar Clinical Development – Scientific Considerations..:

Endrenyi, Laszlo
Journal of Biopharmaceutical Statistics.  27 (2017)  6 - p. 1115-1117 , 2017
Link: https://doi.org/10.1080/..
 
?
7

Algorithms for evaluating reference scaled average bioequiv..:

Tothfalusi, Laszlo ; Endrenyi, Laszlo
Statistics in Medicine.  36 (2017)  27 - p. 4378-4390 , 2017
Link: https://doi.org/10.1002/..
 
?
8

The Two Main Goals of Bioequivalence Studies:

Endrenyi, Laszlo ; Blume, Henning H. ; Tothfalusi, Laszlo
The AAPS Journal.  19 (2017)  4 - p. 885-890 , 2017
Link: https://doi.org/10.1208/..
 
?
9

An Exact Procedure for the Evaluation of Reference-Scaled A..:

Tothfalusi, Laszlo ; Endrenyi, Laszlo
The AAPS Journal.  18 (2016)  2 - p. 476-489 , 2016
Link: https://doi.org/10.1208/..
 
?
10

Guest editor's note: Special issue on biosimilarity assessm..:

Chang, Victoria Yu-Wei ; Endrenyi, Laszlo
Journal of Biopharmaceutical Statistics.  27 (2016)  2 - p. 195-196 , 2016
Link: https://doi.org/10.1080/..
 
?
11

Statistical and regulatory considerations in assessments of..:

Tóthfalusi, Lászlo ; Endrényi, László ; Chow, Shein-Chung
The European Journal of Health Economics.  15 (2014)  - p. S5-S11 , 2014
Link: https://www.jstor.org/st..
 
?
12

Scientific Factors and Current Issues in Biosimilar Studies:

Chow, Shein-Chung ; Endrenyi, Laszlo ; Lachenbruch, Peter A..
Journal of Biopharmaceutical Statistics.  24 (2014)  6 - p. 1138-1153 , 2014
Link: https://doi.org/10.1080/..
 
?
13

Statistical and regulatory considerations in assessments of..:

Tóthfalusi, Lászlo ; Endrényi, László ; Chow, Shein-Chung
The European Journal of Health Economics.  15 (2014)  S1 - p. 5-11 , 2014
Link: https://doi.org/10.1007/..
 
?
14

Approvable generic carbamazepine formulations may not be bi..:

Tothfalusi, Laszlo ; Endrenyi, Laszlo
Int. Journal of Clinical Pharmacology and Therapeutics.  51 (2013)  6 - p. 525-528 , 2013
Link: https://doi.org/10.5414/..
 
?
15

Scientific considerations for assessing biosimilar products:

Chow, Shein‐Chung ; Wang, Jun ; Endrenyi, Laszlo.
Statistics in Medicine.  32 (2012)  3 - p. 370-381 , 2012
Link: https://doi.org/10.1002/..
 
1-15